培朵普利与卡维地洛联合应用治疗充血性心力衰竭

Combination of perindopril and carvedilol in conjestive heart failure

目的 观察血管紧张素转换酶抑制剂 (ACEI)培朵普利和非选择性 β 受体阻滞剂卡维地洛联合应用治疗慢性充血性心力衰竭 (CHF)患者的临床疗效。方法 采用培朵普利和卡维地洛联合治疗CHF患者 34例 ,并与单用培朵普利治疗 30例进行比较。结果 治疗组与对照组的有效率分别为 94 1%和 70 % (P <0 0 5 )。结论 ACEI及非选择性β

Objectives To observe the clinical effects of angiotensin converting enzyme inhibitor (ACEI) perindopril and non selective β receptor blocker carvedilol on conjestive heart failure (CHF). Methods Thirty four patients with CHF were received perindopril and carvedilol (therapy group) and 30 patients were received perindopril alone (control group), the clinical effects between two groups were compared. Results The effective rates of therapy group and control group were 94.1% and 70.0%, respectively ( P <0.05). Conclusions The treatment with combination of perindopril and carvedilol for CHF is safe and effective and its therapeutic effect is better than perindopril alone group.